Last reviewed · How we verify
NCT06769074: PRP
Assessment of Platelet Rich Plasma Injection in Managing Female Patients Complaining of Mixed Urinary Incontinence (PRP)
NA trial testing Platelet Rich Plasma in Mixed Urinary Incontinence in 24 participants. Participants enrolled and being followed up; not accepting new ones.
1 June 2025
Quick facts
| Lead sponsor | Zagazig University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 28 December 2024 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- Platelet Rich Plasma — full drug profile →
Conditions studied
- Mixed Urinary Incontinence — all drugs for Mixed Urinary Incontinence →
Sponsor
Zagazig University
Who can join
Adults 20 to 60, female only, with Mixed Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to assess the efficacy of platelet-rich plasma (PRP) for the treatment of mixed urinary incontinence determine .The main question it aims to answer whether PRP is it safe and effective in managing mixed urinary incontinence? Researchers will assess efficacy of PRP in both stress and urgency incontinence treatment Participants will: * Undergo PRP injection in to mid urethra , and installation into bladder every 1 month for 3 month * Visit the clinic once every 1 month for checkups and urodynamic study after 3 month, and 4 month after last installation
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06769074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Platelet Rich Plasma
Trials testing the same drug.
- NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy · NA · not yet recruiting
- NCT07329361 — Efficacy and Safety of Intra-articular Injections of Frozen Platelet-Rich Plasma in Patients With Knee Osteoarthritis · NA · recruiting
- NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
- NCT06810726 — Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroisc · Phase 2 · recruiting
- NCT06839326 — Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder · NA · completed
Other recruiting trials for Mixed Urinary Incontinence
Currently open trials in the same condition.
- NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
- NCT06480227 — Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence · NA · recruiting
Other Zagazig University trials
Trials by the same sponsor.
- NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
- NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
- NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
- NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
- NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06769074 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zagazig University
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06769074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing